ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022: A Phase II Study of Gem + Cis Chemo in MIBC With Bladder Preservation for Patients Whose Tumors Harbor Deleterious DNA Damage Response Gene Alterations (Alliance A031701)
By
ASCO 2022 Conference Coverage
FEATURING
Gopa Iyer
By
ASCO 2022 Conference Coverage
FEATURING
Gopa Iyer
131 views
June 8, 2022
Comments 0
Login to view comments.
Click here to Login
GU